Work

Correlation among obstructive sleep apnea syndrome, coronary atherosclerosis and coronary heart disease

Year: 2007
Type: article
Study design: Observational Study
Abstract: Epidemiologic investigations have shown that the morbidity of obstructive sleep apnea syndrome (OSAS) among adults is 2%-4%, among the population aged 30 years and over is 4.63%, and among patients with hypertension or coronary atherosclerostic disease (CAD) is as high as 30%-50%.1 Many studies have indicated that OSAS may be closely associated with the development of CAD since increased incidence and mortality of CAD were found in OSAS patients. However, although it has been confirmed that OSAS is an independent risk factor for hypertension, its exact correlation with CAD has not been entirely elucidated. The aim of the present study was to explore the correlation between the degrees of OSAS and CAD with the application of coronary artery angiography (CAA), Gensini scoring evaluation system, and other risk factors which may contribute to CAD. METHODS Subjects From March 2005 to December 2005, a total of 82 patients from Department of Cardiology of the First Affiliated Hospital of Nanjing Medical University were recruited into this study. The exclusion criteria were (1) cardiac insufficiency or heart failure (ejection fraction (EF)<40%); (2) chronic obstructive pulmonary disease and daytime hypoxemia; (3) recently being treated with oxygen therapy or mechanical ventilation; (4) valvular heart diseases and/or cardiomyopathy; (5) recent cerebral apoplexy; (6) variant angina pectoris or X syndrome; (7) central sleep apnea; (8) failing to endure the polysomnography (PSG) monitoring due to their severe symptoms. Based on PSG results, all recruited subjects were divided into 3 groups: mild OSAS group (5< apnea-hypopnea index (AHI)≤20, n=38), moderate-to-severe OSAS group (AHI>20, n=20) and non-OSAS group (the control group, AHI<5, n=24). Polysomnography monitoring A PSG device (Alice 4, Respironics Co., USA) was used to measure and record overnight PSG parameters. OSAS was diagnosed according to national criteria.2 Coronary artery angiography Quantitative analysis of coronary artery stenosis was carried out assessing the images obtained through Judkin's technique with a large-type X-ray machine produced by Siemens Co., Ltd, Germany. The positive result of CAA was defined as the presence of >50% stenosis affecting one or more major coronary vessels while the ≤50% stenosis was considered as a negative result. Gensini score3 Gensini score was used for quantitative analysis of arteries including left coronary artery, left anterior descending coronary artery, left circumflex branch and right coronary artery. Ultrasound cardiogram Left ventricle ejection fraction (LVEF) was obtained analyzing the image of left ventricle. Examination of blood samples Fasting intravenous blood specimens were collected at 6:00 a.m. for testing cholesterol (CHOL), triglycerol (TG), high-density lipoprotein cholesterol (HDL-Cho), apoprotein-A (apo-A), apoprotein-B (apo-B), lipid protein-A (LP-A), fasting blood glucose (FBG), urea, creatinine (CR) and uric acid (UA) with the use of a AU2700 automatic biochemistry analyzer (Olympus Co., Ltd., Japan). Statistical analysis All quantitative parameters were expressed as mean ± standard deviation (SD) while one-way analysis of variance (ANOVA)-SNK test was applied for multiple comparison of quantitative parameters and chi-square test was used for comparison among classification data. The non-parametric Kruskal-Wallis test was used to compare Gensini score among groups and Pearson's correlation coefficient (r) was used to describe the relationship between Gensini score and AHI. A P value of less than 0.05 was considered statistically significant. All parameters were processed statistically by SPSS 11.0 software. RESULTS General characteristics As shown in Table 1, there was a significant difference in AHI and minimal SpO2 (miniSpO2) among three groups (all P<0.05). LVEF was lower in both OSAS groups than in control group (P<0.05). Significant differences were detected between moderate-to-severe OSAS group and control group in the levels of LP-A (P<0.05), FBG (P<0.01) and UA (P<0.05). There was statistical difference between mild OSAS group and control group in body mass index (BMI) (P<0.01), waist hip ratio (WHR) (P<0.01) and neck circumference (NC) (P< 0.05). The other parameters in Table 1 were not statistically different among three groups (all P<0.05).Table 1: Comparison of general characteristics among three groups (mean ± SD)CAD and risk factors As shown in Table 2, the ratios of positive CAA was the lowest in control group and the highest in moderate-to severe OSAS group with a significant difference among three groups (χ2=26.497, P<0.01). The analysis on CAA demonstrated that the percentage of both single and multi-coronary-vessel diseases were significantly higher in mild OSAS group and moderate-to-severe OSAS group than in control group; the CAD in OSAS group was mainly characterized with multi-artery involved. Even though there appeared a tendency of higher Gensini score in mild OSAS group than in control group, no statistical significance was reached. However, Gensini score was significantly higher in moderate-to-severe OSAS group than that in control group (P<0.01). Moreover, a positive correlation was revealed between AHI and Gensini score (r=0.425, P<0.01).Table 2: Comparison of CAA results and coronary atherosclerostic Gensini score among three groupsThe incidence of angina pectoris and myocardial infarction in all OSAS patients was significantly higher than those in control group (88.14% vs 37.5%, P<0.01), while no significant difference between OSAS patients and controls in the incidence of hypertension (χ2=3.649, P>0.05), diabetes (χ2=2.127, P>0.05) and hyperlipidemia (χ2=0.402, P>0.05) (Table 3).Table 3: Comparison of incidence of CAD, HP, DM and HL among three groups (n (%))DISCUSSION According to the findings of sleep heart health study in USA,4 AHI>5 is associated with the increase in cardiovascular risks, which include higher morbidity and mortality of cardiovascular diseases, nocturnal cardiac events such as angina, electrocardiographic ST segment changes and arrhythmia, chronic heart failure, and cardiovascular risk factors. Peker et al5 reported that the incidence of CAD was 44.9% in OSAS patients but 37.5% in non-OSAS patients. It was also found that AHI≤20 was independently associated with acute myocardial infarction and such an independent relationship resulted from the mutual influence between OSAS and myocardial ischemia.6 OSAS is more common in patients with stable myocardial ischemia and myocardial infarction. The clinical manifestations, such as angina and myocardial infarction, become more frequent and evident when the sleep apnea and CAD coexist. Gensini score is used for evaluation of the location, number and narrowing degrees of involved coronary arteries in coronary atherosclerosis. The result of our CAA in Chinese was similar to that from the research by Hayashi et al,7 which revealed a positive correlation between Gensini score and the severity of sleep apnea. It, therefore, suggested OSAS was an important factor influencing the prognosis of CAD. The associated mechanisms may be explained as follows: (1) in OSAS patients there are repeated apneas followed by oxygen desaturation, higher activity of sympathetic nerve system with tachycardia and transient elevation in blood pressure, which can lead to lower oxygen supply and higher oxygen consumption to myocardium, an adverse effect on CAD patients; (2) the capacity of platelets' activation and aggregation were enhanced in OSAS, which can cause increase in occurrence of cardiovascular events; (3) recurrent hypoxia following apnea can trigger the process of oxidative stress, which can further cause lipid peroxidation, vascular endothelial dysfunction,8 increase in concentration of inflammatory factors such as circulating C-reactive protein, fibrinogen, interleukin-6 and so on and all these factors can promote the development of atherosclerosis. Our study suggests that great attention should be paid to the screening of OSAS in CAD patients since OSAS is a risk factor of CAD. In order to reduce morbidity of CAD and to improve CAD and its prognosis, it is of vital clinical importance to carry out proper prevention and treatment for risk factors of cardiovascular diseases including OSAS. The timely diagnosis and treatment of OSAS should therefore be taken into account in secondary prevention of CAD. Sleep-related study should be performed in the clinically stable period in order to minimize the interference of examination results caused by the factors mentioned above. Undoubtedly, well-designed prospective crossover controlled studies with large samples are required to further explore the link between OSAS and CAD as well as associated mechanisms.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W18455668
FWCI:
Cites: 9
Cited by: 15
Related to: 10